Fortune Brands Innovations (FBIN)
NYSEIndustrialsConstruction MaterialsSnapshot 2026-10-30
$44.75+1.40%
Close 2026-10-30 · 1-day change
NYSEIndustrialsConstruction MaterialsSnapshot 2026-10-30
Research Workspace
Put FBIN beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Building Products is in recovery. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Operating margin recovers toward 11% by FY26 end: Operating margin: -0.78%.
View ThesisRevenue is contracting — down about 2% over the past year.
View GrowthRanks among the strongest in its industry on quality — around the top 22%.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 48% in its worst 12-month stretch.
View RiskFBIN’s case rests on improving execution and profitable growth, yet revenue declines have slowed, not reversed. Revenue fell 4.1% year over year in Q2 FY2026, despite an earnings beat. The shares trade at 12× P/E versus a 19× peer median; expectations look modest versus our view. Operating margin remains the pressure point, at -0.78% against a pillar requiring recovery toward 11% by FY26 end. Fragile cash backing also leaves reported profits vulnerable. Peer multiples imply a price about 7% above where it trades; the thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-30. FBIN is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 20 analysts currently covering FBIN (as of Oct 2026).
Based on 9 Wall Street analysts offering 12-month price targets for FBIN in the last 4 months.
Continue this research
Compare FBIN with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| FBIN Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Building Products — fair value, gap to price, and forward P/E.
Compare the value case
Put FBIN next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Focus on improving execution and driving profitable growth
Divestiture reshapes the portfolio, but no stated terms or proceeds establish a thesis-changing impact.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $44.75
The last 12 months of price, then the range of analyst 12-month targets from today’s $44.75.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Leadership transition and strengthening management team
New CFO strengthens management team and execution focus.
Advances: Leadership transition and strengthening management team
Board restructuring aligns with strengthening management team objective.
Advances: Focus on revenue growth
Favorable demand trends support revenue growth objective.
Advances: Focus on revenue growth
Director's stock purchase signals confidence in revenue growth.